Ligand profile
ZINC2276591
Virtual-screening candidate from ZINC.
Bound to: KP13_01311 — Methylmalonate semialdehyde dehydrogenase acylating
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2276591- UniProt (similar protein)
P00352- Tanimoto
- 1.000
- Target protein
- KP13_01311
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 58.7
- −1 ≤ LogP ≤ 5 2.82
- MW ≤ 500 Da 291.4
- LogP ≤ 5 2.82
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 58.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C=CCn1c(SCC#N)nc2sc(CC)cc2c1=OC=CCn1c(SCC#N)nc2sc(CC)cc2c1=O
InChI=1S/C13H13N3OS2/c1-3-6-16-12(17)10-8-9(4-2)19-11(10)15-13(16)18-7-5-14/h3,8H,1,4,6-7H2,2H3InChI=1S/C13H13N3OS2/c1-3-6-16-12(17)10-8-9(4-2)19-11(10)15-13(16)18-7-5-14/h3,8H,1,4,6-7H2,2H3
CTEQCDVQLGSRLC-UHFFFAOYSA-NCTEQCDVQLGSRLC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL1549138
- Homolog
- P00352
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2276591 →
- ZINC ZINC20 ZINC2276591 →
- UniProt UniProt P00352 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2276591”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01311.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).